The price of Tempest Therapeutics Inc (NASDAQ:TPST) shares last traded on Wall Street fell -5.13% to $1.11.
TPST stock price is now -15.63% away from the 50-day moving average and -60.54% away from the 200-day moving average. The market capitalization of the company currently stands at $27.98M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $13, Scotiabank recently initiated with Sector Outperform rating for Tempest Therapeutics Inc (NASDAQ: TPST). On February 08, 2024, Jefferies recently initiated its ‘Buy’ rating on the stock quoting a target price of $15
In other news, Versant Venture Capital VI, L., Owner bought 387,999 shares of the company’s stock on Aug 12 ’24. The stock was bought for $426,993 at an average price of $1.10. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 08 ’24, 10% Owner Versant Venture Capital VI, L. sold 400,000 shares of the business’s stock. A total of $540,040 was realized by selling the stock at an average price of $1.35. This leaves the insider owning 597,940 shares of the company worth $0.66 million. A total of 15.95% of the company’s stock is owned by insiders.
During the past 12 months, Tempest Therapeutics Inc has had a low of $0.92 and a high of $9.00. As of last week, the company has a debt-to-equity ratio of 1.20, a current ratio of 2.17, and a quick ratio of 2.17. The fifty day moving average price for TPST is $1.32404 and a two-hundred day moving average price translates $2.829385 for the stock.
The latest earnings results from Tempest Therapeutics Inc (NASDAQ: TPST) was released for 2024-06-30. The company reported revenue of $9.58 million for the quarter, compared to $7.47 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 28.27 percent.
